Showing results (141-150 of 159) with videos related to
Sort By:
Pageof 16
JAMA|July 5, 1995
Incidence of adverse drug events and potential adverse drug events. Implications for prevention. ADE Prevention Study GroupD W Bates, D J Cullen, N Laird, et al.Journal of the American Medical Informatics Association : JAMIA|June 3, 1998
Identifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary reportA K Jha, G J Kuperman, J M Teich, et al.Health Care Financing Review|August 3, 2001
Principal inpatient diagnostic cost group model for Medicare risk adjustmentG C Pope, R P Ellis, A S Ash, et al.JAMA|December 12, 2001
Guided medication dosing for inpatients with renal insufficiencyG M Chertow, J Lee, G J Kuperman, et al.American Journal of Veterinary Research|September 1, 1988
Evaluation of the stable fly (Stomoxys calcitrans) as a vector of enzootic bovine leukosisA F Weber, R D Moon, D K Sorensen, et al.The American Journal of Medicine|September 1, 1996
Health status in patients with chronic fatigue syndrome and in general population and disease comparison groupsA L Komaroff, L R Fagioli, T H Doolittle, et al.Annals of Internal Medicine|July 1, 1996
The appropriateness of coronary artery bypass graft surgery in academic medical centers. Working Group of the Appropriateness Project of the Academic Medical Center ConsortiumL L Leape, L H Hilborne, J S Schwartz, et al.The American Journal of Medicine|May 7, 1999
A randomized trial of a computer-based intervention to reduce utilization of redundant laboratory testsD W Bates, G J Kuperman, E Rittenberg, et al.Applied Clinical Informatics|July 16, 2014
Relationship between documentation method and quality of chronic disease visit notesP M Neri, L A Volk, S Samaha, et al.Archives of Internal Medicine|November 26, 1999
Patient risk factors for adverse drug events in hospitalized patients. ADE Prevention Study GroupD W Bates, E B Miller, D J Cullen, et al.Pageof 16